Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Z Best Place to Talk Stocks -- Ignore unavailable to you. Want to Upgrade?

To: E.J. Neitz Jr who wrote (40697)	6/17/2002 6:20:39 PM
From: DanZ	Respond to of 53068

I just got a news alert that Gum Tech will release five new products. This company still only has 10 million shares outstanding, and the two existing Zicam products have gross profit margins of 75 to 80 percent. We should get a glimpse at initial sales at tomorrow's annual meeting, but with such a high gross margin, I would expect the marginal profit on these new sales to be quite high. Five New Zicam(R) Products Introduced At National Association of Chain Drug Stores Marketplace Meeting PR NEWSWIRE - June 17, 2002 18:05 PHOENIX, Jun 17, 2002 /PRNewswire-FirstCall via COMTEX/ -- Gum Tech International, Inc. (Nasdaq: GUMM), the developer and distributor of Zicam(R) Cold Remedy and Zicam Allergy Relief, has introduced five new Zicam products at the National Association of Chain Drug Stores (NACDS) Marketplace meeting, taking place June 15-18, 2002 in San Diego, California. The new cough and cold products will build on the successful Zicam franchise and are based on formulas using Gum Tech's patented, proprietary nasal gel matrix technology, said Carl J. Johnson, president and chief executive officer of Gum Tech International, Inc. The new products include: Zicam Cold Remedy Swabs, Zicam Kids Size Cold Remedy Swabs, Zicam Extreme Congestion Relief, Zicam Sinus Relief, and Zicam Nasal Moisturizer. "These are the first of an array of new products from Gum Tech," said Mr. Johnson. "We intend to continue developing and marketing innovative, over-the-counter drug application and delivery systems, offering consumers ready access to effective, reasonably-priced healthcare products."